Position in EYPT
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$10,743,234
+$540,944 QoQ
Shares Held
833,455
+16.3% QoQ
Ownership
0.994%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HSBC HOLDINGS PLC holds $961,918,485 across 122 Biotechnology names. EYPT ranks #15 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
655,443 | $292,681,510 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
323,338 | $249,823,869 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,544,018 | $74,066,541 | |
| 4 | INCY |
Incyte Corp
|
582,368 | $54,812,474 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
89,619 | $29,652,235 | |
| 6 | MRNA |
Moderna, Inc.
|
490,088 | $24,896,468 | |
| 7 | INSM |
INSMED Inc
|
116,456 | $19,042,883 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
227,059 | $15,469,528 |
All Filings in EYPT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,743,234 | 833,455 | Shares | Defined | 2026-04-30 | |
| 2025-09-30 | $10,202,290 | 716,453 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,938,405 | 631,074 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $3,388,257 | 625,140 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,919,231 | 257,615 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,029,348 | 253,986 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||